Low extracellular calcium (Ca 2ϩ ) promotes release of parathyroid hormone (PTH), which acts on multiple organs to maintain overall Ca 2ϩ balance. In the distal part of the nephron, PTH stimulates active Ca 2ϩ reabsorption via the adenylyl cyclase-cAMP-protein kinase A (PKA) pathway, but the molecular target of this pathway is unknown. The transient receptor potential vanilloid 5 (TRPV5) channel constitutes the luminal gate for Ca 2ϩ entry in the distal convoluted tubule and has several putative PKA phosphorylation sites. Here, we investigated the effect of PTH-induced cAMP signaling on TRPV5 activity. Using fluorescence resonance energy transfer, we studied cAMP and Ca 2ϩ dynamics during PTH stimulation of HEK293 cells that coexpressed the PTH receptor and TRPV5. PTH increased cAMP levels, followed by a rise in TRPV5-mediated Ca 2ϩ influx. PTH (1 to 31) and forskolin, which activate the cAMP pathway, mimicked the stimulation of TRPV5 activity. Remarkably, TRPV5 activation was limited to conditions of strong intracellular Ca 2ϩ buffering. Cell surface biotinylation studies demonstrated that forskolin did not affect TRPV5 expression on the cell surface, suggesting that it alters the single-channel activity of a fixed number of TRPV5 channels. Application of the PKA catalytic subunit, which phosphorylated TRPV5, directly increased TRPV5 channel open probability. Alanine substitution of threonine-709 abolished both in vitro phosphorylation and PTH-mediated stimulation of TRPV5. In summary, PTH activates the cAMP-PKA signaling cascade, which rapidly phosphorylates threonine-709 of TRPV5, increasing the channel's open probability and promoting Ca 2ϩ reabsorption in the distal nephron.
Calcium (Ca 2ϩ ) is essential for numerous physiologic functions and many cellular processes, including signal transduction, cell motility, and morphology. 1, 2 The body maintains extracellular Ca 2ϩ levels within a narrow range. Slight perturbations in Ca 2ϩ homeostasis are detected by the Ca 2ϩ -sensing receptor, located in the parathyroid glands. 3 Low extracellular Ca 2ϩ levels inhibit Ca 2ϩ -sensing receptor activity, causing the release of parathyroid hormone (PTH) into the circulation. 3, 4 In the kidney, PTH reduces Ca 2ϩ excretion by stimulating Ca 2ϩ reabsorption from the distal part of the nephron. 5 Secreted PTH consists of 84 amino acids. Upon binding to the PTH receptor (PTH1R), it is able to activate both protein kinase C (PKC), via phospholipase C (PLC), and adenylyl cyclase-cAMP, depending on the cell type. 6, 7 Activation of the latter pathway requires the first two residues within the amino-terminus of PTH. Consequently, PTH (3 to 34) does not affect basal cAMP levels in contrast to PTH (1 to 34). 8 -10 Use of full-length PTH and these fragments has implicated both path-ways in PTH-induced stimulation of renal Ca 2ϩ reabsorption. 5, 7, 11, 12 The transient receptor potential vanilloid 5 (TRPV5) Ca 2ϩ channel constitutes the apical entry gate for active (transcellular) Ca 2ϩ reabsorption from the distal part of the nephron. 13, 14 It is, therefore, a likely target of PTH. Support for this notion is provided by the observation that long-term exposure to PTH enhances TRPV5 activity via two distinct mechanisms. PTH increases TRPV5 expression 15 and causes accumulation of the channel at the plasma membrane. The latter effect involves PLC signaling and a subsequent PKC-dependent phosphorylation. 16 In contrast, the molecular target for the adenylyl cyclase-cAMP-protein kinase A (PKA) pathway activated by PTH has not been identified. Using ex vivo models of active Ca 2ϩ reabsorption, PTH-induced cAMP signaling was demonstrated to be essential for rapid stimulation of luminal Ca 2ϩ uptake. 5, 11, 17, 18 Interestingly, primary cultures of isolated rabbit connecting tubules (CNT) and cortical collecting duct cells, which express endogenous TRPV5, displayed increased transcellular Ca 2ϩ transport after exposure to forskolin or cAMPelevating hormones, including PTH. 12, 19, 20 Thus, despite the large number of studies investigating the role of PTH in renal Ca 2ϩ handling, the molecular mechanism connecting the cAMP pathway with subsequent stimulation of active Ca 2ϩ reabsorption has not yet been determined. Because TRPV5 has several putative PKA phosphorylation sites and is fundamental to renal Ca 2ϩ handling, this channel is a likely target for PTH stimulation via the cAMP-signaling pathway.
The aim of this study, therefore, was to elucidate the potential role of TRPV5 in PTH-induced stimulation of transcellular Ca 2ϩ reabsorption via cAMP-PKA signaling. First, we confirmed that PTH increases 45 Ca 2ϩ influx in HEK293 cells co-expressing TRPV5 and PTH1R. Next, after exposure to PTH we monitored intracellular Ca 2ϩ , phosphatidylinositol-4,5bisphosphate (PIP 2 ) and cAMP levels in this model system by dynamic fluorescence resonance energy transfer (FRET) assays. Furthermore, we investigated the consequence of forskolin-induced cAMP elevation on TRPV5 function. Finally, we determined TRPV5 cell surface abundance and single channel activity after activation of the cAMP-PKA signaling cascade.
RESULTS

PTH Induces a Sustained Increase in TRPV5-Mediated Ca 2؉ Influx
For studying the role of PTH on TRPV5 activity, TRPV5 and PTH1R were coexpressed in HEK293 cells and treated for 10 min with 10 nM PTH, and, subsequently, we determined the 45 Ca 2ϩ influx rate. Because TRPV5 is known to be rapidly inactivated by elevated intracellular Ca 2ϩ levels, 21 we pretreated the cells with 25 M 1,2-bis-(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetra-acetic acid-acetoxymethyl ester (BAPTA-AM), a cell-permeable Ca 2ϩ buffer. Under these conditions, we observed a significant enhancement of TRPV5 activity by PTH ( Figure 1A ). Ruthenium red, a selective blocker of TRPV5, 22 inhibited 45 Ca 2ϩ uptake under control and PTHstimulated conditions ( Figure 1A) .
To measure the acute effect of PTH on TRPV5 function, HEK293 cells were transfected with yellow cameleon 2.1, a FRET sensor that detects free intracellular Ca 2ϩ . Figure 1B shows a typical example of a calibrated FRET trace. FRET was normalized to a minimum value, obtained after addition of 4 mM BAPTA (point B) in combination with 5 M of the Ca 2ϩ Figure 1 . PTH rapidly induces a sustained stimulation of TRPV5-mediated Ca 2ϩ influx. (A) 45 Ca 2ϩ influx in HEK293 cells transiently coexpressing PTH1R and TRPV5, pretreated for 30 min with 25 M BAPTA-AM. All procedures were performed at 37ЊC, and PTH or DMSO solvent (CTR) was administered simultaneously with 45 Ca 2ϩ . *P Ͻ 0.05 versus CTR. TRPV5-specific 45 Ca 2ϩ influx was determined by addition of 10 M ruthenium red (RR). (B) Representative trace of intracellular Ca 2ϩ upon PTH stimulation using yellow cameleon 2.1 as a FRET sensor. (C) Basal calibrated Ca 2ϩ levels in HEK293 cells transfected with mock (n ϭ 8) and TRPV5 (n ϭ 9). *P Ͻ 0.05 versus mock. (D) Average trace of intracellular Ca 2ϩ levels of TRPV5 upon treatment with PTH (n ϭ 9). (Inset) Relative FRET Ca 2ϩ increase from basal to PTH-stimulated conditions, as shown by time periods "A" and "B," respectively. *Significant difference (P Ͻ 0.05) from basal conditions.
ionophore ionomycin (point C), and a maximum value was reached after addition (point D) of 8 mM CaCl 2 . These experiments revealed that basal intracellular Ca 2ϩ concentrations in HEK293 cells expressing wild-type TRPV5 (TRPV5-WT) were significantly higher than mock-transfected cells ( Figure 1C ). PTH stimulation of TRPV5-expressing cells resulted in a further steady increase of the intracellular Ca 2ϩ concentration, starting 40 to 50 s after addition of PTH and leveling off after approximately 3 min ( Figure 1D ). In the presence of PTH, the intracellular Ca 2ϩ concentration was significantly greater than under the control conditions, as shown in Figure 1D .
PTH-Induced Activation of the cAMP Signaling Cascade Stimulates TRPV5
To study the role of PKC in PTH-dependent acute activation of TRPV5, we used a TRPV5 mutant lacking all six putative PKC consensus sites (TRPV5-PKC6) 23 . A previous study demonstrated that two of these PKC consensus sites play a crucial role in the PTH-induced accumulation of TRPV5 at the cell surface. 16 This long-term TRPV5 activation was shown to depend on PLC signaling and subsequent PIP 2 breakdown. 23 Interestingly, treatment of HEK293 cells coexpressing PTH1R and TRPV5-PKC6 with PTH enhanced 45 Ca 2ϩ influx to a similar extent as TRPV5-WT ( Figure 2A ). Because these results suggested the involvement of an alternative signaling pathway, we used FRET sensors for intracellular PIP 2 24 and cAMP. 25 Figure  2B depicts a typical FRET trace for the PIP 2 sensor under resting conditions (t ϭ 0 min) and during maximal stimulation using 5 M ionomycin and 8 mM CaCl 2 to activate Ca 2ϩdependent PLCs. 26 We did not detect PIP 2 breakdown after treatment with 10 nM PTH, using HEK293 cells with (n ϭ 6) or without (n ϭ 4; data not shown) TRPV5 coexpression (Figure 2B ). Using the Epac-based FRET sensor, the intracellular cAMP levels were monitored in PTH-stimulated HEK293 cells. A representative trace is presented in Figure 2C . The FRET results were expressed by normalizing traces between the resting value (at t ϭ 0 min) and a maximum value, which was induced by treatment with 50 M forskolin and 0.5 mM isobutylmethylxanthine. In Figure 2D , mean cAMP levels upon addition of PTH are depicted. PTH induced a rapid elevation of cAMP that reaches a plateau after 9 min. This stimulation was 80 to 90% of the maximum FRET values.
To study the involvement of the cAMP pathway in PTHinduced TRPV5 activation in more detail, we used different PTH fragments. The biologic active part of PTH is compromised by the first 34 amino acids. The first two residues of the N-terminus are required for a cAMP response. 10 Consistent with a PTH-specific elevation in cAMP levels PTH (1 to 31), in contrast to PTH (3 to 34), rapidly increased cAMP levels (Figure 2E ). Compelling evidence for the crucial role of cAMP in TRPV5 activation was gained by measuring intracellular Ca 2ϩ . PTH (1 to 31) treatment induced a sustained raise of intracellular Ca 2ϩ , which reached a maximal effect after approximately 3 min ( Figure 2F ). In contrast, PTH (3 to 34) did not affect intracellular Ca 2ϩ concentrations ( Figure 2F ).
Forskolin Mimics the PTH-Dependent Activation of TRPV5
We used forskolin to study directly the role of cAMP in the regulation of TRPV5 channel activity. We determined the influx of 45 Ca 2ϩ in HEK293 cells transiently expressing TRPV5 treated with 10 M forskolin for 10 min. Forskolin signifi- BASIC RESEARCH www.jasn.org cantly increased TRPV5 activity, fully mimicking PTH stimulation ( Figure 3A ). Again, ruthenium red blocked TRPV5-mediated 45 Ca 2ϩ uptake under both control and forskolin-treated conditions ( Figure 3A ). Subsequently, we investigated the potential involvement of PKA in the activation of TRPV5, because forskolin is a widely known activator of this enzyme; therefore, HEK293 cells transiently expressing TRPV5 were pretreated for 30 min with 10 M H-89, a selective blocker of PKA activity. 27 This abolished the forskolin-induced stimulation of TRPV5 activity ( Figure 3B ). To determine the specificity of the PKA-mediated increase in TRPV5 activity, we used the closely related epithelial Ca 2ϩ channel, TRPV6, known as the luminal entry gate for intestinal Ca 2ϩ absorption. 28 Acute forskolin treatment did not alter TRPV6 activity in either the presence or the absence of buffers to chelate intracellular Ca 2ϩ ( Figure 3C ), confirming that the forskolin-induced channel activation is specific for TRPV5.
Under conditions lacking an intracellular buffer for Ca 2ϩ , forskolin did not noticeably affect TRPV5-mediated 45 Ca 2ϩ influx ( Figure 3D ). PTH also failed to increase 45 Ca 2ϩ influx under these conditions (40 Ϯ 5 and 46 Ϯ 6 pmol/min per mg for control and PTH, respectively; P Ͼ 0.2). Next, we used EDTA-acetoxymethyl ester (EDTA-AM), a buffer with relatively slow Ca 2ϩ -binding kinetics relative to BAPTA-AM, 29 to study further the role of Ca 2ϩ buffering in TRPV5 regulation by forskolin. Pretreatment with EDTA-AM and subsequent forskolin stimulation increased TRPV5 activity, although less pronounced compared with BAPTA-AM pretreatment (Figure 3D) . Importantly, the Ca 2ϩ -binding protein calbindin-D 28K , which co-localizes with TRPV5 in renal tubular epithelial cells, 30, 31 acts as a natural cytosolic Ca 2ϩ buffer. The coexpression of calbindin-D 28K in HEK293 cells also permitted a significant increase of 45 Ca 2ϩ influx upon forskolin treatment ( Figure 3D ).
Next, we investigated the role of intracellular Ca 2ϩ on forskolin-induced activation of TRPV5 using patch-clamp analysis. Forskolin did not alter TRPV5-mediated Na ϩ currents in the ruptured whole-cell mode (Supplemental Figure 1) ; therefore, we further investigated TRPV5 regulation by amphotericin B-perforated patch-clamp analysis. In this configuration, forskolin rapidly elevated whole-cell Na ϩ currents ( Figure 3E ). Subsequently, we treated cells with BAPTA-AM. In comparison with untreated conditions, BAPTA-AM treatment did not significantly increase the basal Na ϩ current (106 Ϯ 5%; n ϭ 13; P Ͼ 0.2), indicating that the basal intracellular Ca 2ϩ concentration does not inhibit TRPV5 activity. Importantly, BAPTA-AM pretreatment amplified the forskolin-mediated stimulation of TRPV5 ( Figure 3E ). 
PKA-Mediated TRPV5 Stimulation Depends on Threonine Residue 709
Next, we inquired whether the forskolin-mediated TRPV5 stimulation was due to a direct phosphorylation of the channel by PKA. To identify putative PKA consensus sites in TRPV5, we used the prediction server NetPhosk (http://www.cbs. dtu.dk/services). Computational analysis of the TRPV5 amino acid sequence of four different mammalian species resulted in the identification of three highly conserved PKA consensus sites ( Figure 4A ). Of the putative phospho-residues, one serine was located in the N-tail (S142), whereas the C-tail harbored the other putative sites, another serine and a threonine residue (S680 and T709). Using site-directed mutagenesis, each residue was substituted for an alanine. Replacement of the T709 residue with alanine abolished forskolin-stimulated 45 Ca 2ϩ uptake, whereas mutation of S142 or S680 did not prevent the TRPV5 activation by forskolin ( Figure 4B ). Again, forskolin stimulation of TRPV5-PKC6 did not differ from stimulation of TRPV5-WT ( Figure 4B ). Importantly, TRPV5 protein expression was not affected by the introduction of these mutations ( Figure 4C ). The essential role of T709 in forskolin-induced TRPV5 activation was further supported by perforated patch analysis (Supple-mental Figure 2 ) and FRET analysis ( Figure 4D) . Forskolin significantly increased the intracellular Ca 2ϩ concentration of cells expressing TRPV5-WT; however, no effect was observed for TRPV5-T709A ( Figure 4D ). Likewise, TRPV5 activation by PTH also required an intact T709 phosphorylation site (Supplemental Figure 3) .
To confirm the crucial role of T709 in PKA-mediated TRPV5 stimulation, we performed in vitro phosphorylation experiments using the amino (N)-or carboxyl (C)-tail of TRPV5 fused to glutathione S-transferase (GST). Proteins were incubated for 30 min in the presence of [␥ 32 P]ATP and the purified catalytic subunit of PKA. Equal loading was verified by Coomassie staining, as shown in the Figure 4E , top. Robust 32 P-phosphorylation was detected for the GST C-tail, whereas no radioactivity was present for the GST N-tail or for GST alone ( Figure 4E ). In contrast to 32 P labeling of GST C-tail harboring the S680A mutation, substitution of T709 by alanine significantly reduced 32 P labeling of the C-tail, confirming the critical role of T709.
Molecular Mechanism of PKA-Induced TRPV5 Activity
We next addressed the molecular mechanism mediating the rapid increase of TRPV5 activity upon forskolin treatment. To BASIC RESEARCH www.jasn.org this end, we pretreated HEK293 cells expressing TRPV5-WT or TRPV5-T709A with 25 M BAPTA-AM, stimulated them for 10 min with forskolin, and subjected them to cell surface biotinylation. Cells were lysed, and biotinylated proteins were precipitated with neutravidin-agarose beads. Using immunoblotting, TRPV5 expression in total cell lysates and plasma membrane fraction was determined as depicted by Figure 5 , A and B, respectively. Forskolin treatment did not affect the cell surface expression of TRPV5 ( Figure 5B ), suggesting that an alteration in the single-channel activity of a fixed number of channels is responsible for the PTH-mediated increase in TRPV5 activity.
TRPV5 channel activity, therefore, was measured with the cell-attached patch-clamp technique. Using HEK293 cells transiently expressing TRPV5, we attached the patch pipette to the cell without disrupting the membrane, and we recorded TRPV5 channel current using Na ϩ as a charge carrier. As previously reported, 32 virtually no channel activity was observed at positive membrane potentials ( Figure 6A ). The currentvoltage (I-V) relationship established in response to a voltage ramp from Ϫ100 to 80 mV revealed an average single-channel conductance of 90 Ϯ 11 pS (n ϭ 7). Such channel activity was not present in nontransfected cells. Amplitude histogram analysis of the Ϫ80 mV recording revealed the presence of two channels in the patch ( Figure 6A ). Having established a stable recording of TRPV5 channel current at Ϫ80 mV, we added forskolin to the bath solution. Figure 6B ). Subsequently, we compared mean NPo data during control conditions (min 0 to 1) and after forskolin addition (min 3 to 4). Representative channel openings of TRPV5-WT and TRPV5-T709A are depicted in Figure 6 , C and D, respectively. During control conditions, channel activity of TRPV5-WT and TRPV5-T709A was not significantly different; however, the number of TRPV5-WT channel openings was increased during forskolin treatment ( Figure 6E ), whereas TRPV5-T709A was not affected ( Figure 6F ).
To investigate whether phosphorylation directly influences TRPV5 single-channel activity, we used inside-out singlechannel patch-clamp analysis. Channel activity was restricted to recordings at negative potentials ( Figure 7A ). From the current-voltage (I-V) relationship, we calculated an average channel conductance of 39 Ϯ 2 pS. Amplitude histogram analysis of the Ϫ80 mV recording revealed the presence of a single channel in the patch ( Figure 7A ). The effect of PKA was tested at a holding potential of Ϫ80 mV. After excision of the plasma membrane, 1 mM ATP and 250 U/ml catalytic PKA were cumulatively added to the patch-clamp recording chamber. Application of the PKA subunit increased TRPV5-WT singlechannel activity (Figure 7, B and D) , whereas TRPV5-T709A single-channel activity was not significantly altered ( Figure 7 , C and E).
DISCUSSION
This study delineates the molecular mechanism responsible for TRPV5 channel activation by PTH. HEK293 cells coexpressing TRPV5 and PTH1R demonstrated elevated cAMP levels upon the addition of PTH and a subsequent increase in cytosolic Ca 2ϩ . This latter finding was due to enhanced TRPV5 activity. Activation of the cAMP-PKA pathway, using PTH (1 to 31) or forskolin, mimicked completely the PTH stimulation. Both sufficient Ca 2ϩ buffering and PKA function were necessary for this increased TRPV5-mediated Ca 2ϩ influx. A PKA-dependent phosphorylation of T709 was found to be essential for TRPV5 activation by PTH or forskolin. Finally, PTH-induced TRPV5 activity was not due to an increase in the number of functional channels at the plasma membrane but instead was found to be the result of an enhanced single-channel open probability of a fixed number of TRPV5 channels at the cell surface.
To our knowledge, this is the first study providing a molecular model linking the well-established role for cAMP-PKA signaling after PTH1R engagement to the stimulation of Ca 2ϩ reabsorption from the pro-urine in the distal part of the nephron. Whereas the majority of Ca 2ϩ reabsorption takes place in the proximal tubule and thick ascending limb of Henle via passive paracellular transport, only approximately 15% is actively reabsorbed in DCT and CNT 33 ; however these last two nephron segments control the renal excretion of Ca 2ϩ and are the target of PTH, which activates the cAMP signaling cascade, eventually enhancing Ca 2ϩ reabsorption. 11, 18, 34, 35 Use of the adenylyl cyclase-activating compound, forskolin, and cell-permeable cAMP analogs in ex vivo models of active Ca 2ϩ reabsorption mimicked the stimulatory effect of PTH. 11, 17, 19, 20, 36, 37 Several studies suggested that PTH positively influences the uptake of Ca 2ϩ from the pro-urine, although the specific protein mediating the apical influx of Ca 2ϩ was unknown. 5, 17, 18 In 1999, Hoenderop et al. 38 identified TRPV5 as the apical uptake mechanism for active Ca 2ϩ reabsorption in DCT and CNT. Functional analysis of TRPV5 knockout mice supported this notion, because the mean Ca 2ϩ delivery to puncturing sites in DCT was significantly higher than wild-type mice. 13 These findings suggest that TRPV5 is the molecular target of PTH-induced Ca 2ϩ reabsorption from the distal part of the nephron. Using HEK293 cells coexpressing TRPV5 and PTH1R, we were able to reproduce the cAMP-mediated stimulation of Ca 2ϩ influx upon the addition of PTH, as is observed in native tissue (i.e., the kidney).
Buffering intracellular Ca 2ϩ was found to be crucial for an increased TRPV5-mediated 45 Ca 2ϩ influx by forskolin. Interestingly, no additional buffer for Ca 2ϩ was required for TRPV5 stimulation in the FRET assays. This is likely due to the Ca 2ϩchelating effect of calmodulin residing in the yellow cameleon 2.1. 39 In contrast to EDTA-AM pretreatment, the addition of BAPTA-AM increased 45 Ca 2ϩ uptake of cells not stimulated with forskolin. This finding is in line with the fast binding kinetics of BAPTA compared with EDTA. 29, 40 Both EDTA-AM and BAPTA-AM allowed TRPV5 activation by forskolin. Thus, in contrast to other ion channels, fast Ca 2ϩ buffering is not BASIC RESEARCH www.jasn.org crucial for TRPV5 activity. Coexpression of calbindin-D 28K also buffered intracellular Ca 2ϩ sufficiently to permit forskolin-induced TRPV5 stimulation. This Ca 2ϩ -binding protein specifically co-localizes with TRPV5 in DCT and CNT and has been shown to play a crucial role in active Ca 2ϩ reabsorption in vivo. 31, 41 At low intracellular Ca 2ϩ concentration, calbindin-D 28K moves to a position near the plasma membrane and binds directly to TRPV5. The associated calbindin-D 28K tightly buffers TRPV5-mediated Ca 2ϩ influx. Hereby, transcellular Ca 2ϩ transport is stimulated as TRPV5 inactivation is prevented by the lowered intracellular Ca 2ϩ concentration. 31 The observation that TRPV5 and calbindin-D 28K co-localize to the apical region of DCT and CNT supports our finding that acute TRPV5 stimulation by PTH requires the local presence of a Ca 2ϩ -binding protein.
PKA plays a crucial role in forskolin-mediated TRPV5 activation. This is confirmed by the abolishment of TRPV5 stimulation by H-89, a PKA blocker. The threonine at position 709 in TRPV5, a PKA consensus site, is essential for the activation of TRPV5 by this mechanism, as demonstrated by 45 Ca 2ϩ uptake, FRET imaging, and patch-clamp analysis. In vitro, PKA phosphorylation of the TRPV5 C-tail was virtually abolished upon alanine substitution of T709. The remaining minor radioactive signal of the T709A mutant could possibly be due to an additional PKA site. It is of interest that only the threonine residue is completely conserved in all studied species, whereas S142 and S680, the other putative phosphorylation sites, not involved in forskolin-mediated TRPV5 activation, were absent in nonmammalian species. Furthermore, amino acid alignment with the close homologue TRPV6 failed to reveal a conserved putative PKA consensus site in proximity to TRPV5-T709. Consistent with this, forskolin did not affect TRPV6 activity, confirming the specificity of TRPV5 activation. Interestingly, PTH likely does not effect the intestinal absorption of Ca 2ϩ , in which TRPV6 is the proposed luminal influx mechanism for Ca 2ϩ . 42 Using cell surface biotinylation assays and patch-clamp analysis, the direct molecular mechanism responsible for PTH-induced TRPV5 activation was elucidated. Because forskolin-mediated PKA activation did not affect TRPV5 plasma membrane expression, we studied single-channel activity in the cell-attached and inside-out configuration. TRPV5 channel conductance (90 pS) in cell-attached patch-clamp analysis was similar to our previously published values. 32 In addition, inside-out recordings revealed an average conductance of 39 pS, which is slightly lower than the previously reported values. 32, 43 In our collaborative study with Nilius et al., 32 we demonstrated variability in the single-channel conductance ranging from 55 to 95 pS. Use of different solutions and pH in the individual reports might provide an explanation for the differences in channel conductance between these studies. 43 Using the cell-attached as well as inside-out configuration TRPV5 single-channel activity was studied in response to forskolin and the catalytic PKA subunit. A significant increase in TRPV5 open probability was measured in both configurations, whereas channel activity of TRPV5-T709A was not altered. Thus, our data suggest that PTH augments the open probability of TRPV5 channels via a PKA-dependent phosphorylation, which in turn results in an increased TRPV5-mediated Ca 2ϩ influx.
The stimulatory effect of PTH and forskolin on TRPV5 activity in HEK293 cells was detected only at low intracellular Ca 2ϩ concentrations. Thus, PKA-mediated TRPV5 stimulation seems to rely on an unidentified Ca 2ϩ -sensitive pathway. To investigate further the role of intracellular Ca 2ϩ on TRPV5 stimulation by PKA, we initiated perforated patch-clamp recordings. TRPV5 activity was determined by measuring the whole-cell Na ϩ current. In contrast to the 45 Ca 2ϩ uptake assay, no additional Ca 2ϩ buffering was required to observe TRPV5 stimulation by forskolin. The absence of Ca 2ϩ influx via TRPV5 in this latter patch-clamp configuration prevents an increase in intracellular Ca 2ϩ concentration and therefore allows stimulation of channel activity by forskolin. Subsequently, cells were treated with BAPTA-AM. In comparison with the control condition, BAPTA-AM treatment did not significantly increase the basal TRPV5-mediated Na ϩ current. This indicates that under these conditions, the basal intracellular Ca 2ϩ concentration does not inhibit TRPV5 activity; however, BAPTA-AM pretreatment amplified the forskolinmediated stimulation of TRPV5. In a previous study performed in MDCK cells stably expressing TRPV5, forskolin increased TRPV5-mediated Ca 2ϩ influx without the presence of an additional Ca 2ϩ buffer. 44 Differences in basal Ca 2ϩ concentrations between TRPV5-expressing HEK293 and MDCK cells might provide an explanation for this observation. Further research is needed to identify the exact Ca 2ϩ -sensitive pathway preventing TRPV5 stimulation at increased intracellular Ca 2ϩ concentrations.
In addition to the Ca 2ϩ -sensitive cAMP-PKA signaling pathway, PTH has been reported to affect TRPV5 function via other molecular mechanisms. 13, 45 Several groups have demon-strated that PKC is required for the PTH-mediated increase in Ca 2ϩ reabsorption. 12, 46 Recently, Cha et al. 16 confirmed the crucial role of PLC-PKC signaling in PTH-induced TRPV5 stimulation. Activation of the PKC pathway reduced caveolaemediated TRPV5 endocytosis, resulting in an increased channel activity 16 ; therefore, a 15-min pretreatment with PTH was required. Furthermore, the TRPV5 channel lacking both PKC phosphorylation sites did not respond to PTH. 16 Interestingly, in our experiments, PTH stimulation of the TRPV5 channel missing these PKC sites was identical to TRPV5-WT. These distinctive data might result from differences in the experimental setup. Cha et al. 16 applied 120 nM PTH for 15 min to activate a PKC-signaling pathway, whereas we demonstrated TRPV5 channel activity with 10 nM PTH within 5 min, suggesting that moderate stimulation of PTH1R fully triggers the cAMP-PKA pathway.
In 2005, van Abel et al. 15 demonstrated that PTH upregulates TRPV5 expression, which increases active Ca 2ϩ reabsorption via a long-term manner. Parathyroidectomized rats displayed a downregulation of TRPV5 protein expression, whereas long-term PTH supplementation restored the expression. Thus, besides stimulating TRPV5 protein expression and plasma membrane localization, PTH rapidly elevates TRPV5 channel activity, highlighting the essential role for PTH as the in vivo mediator of renal Ca 2ϩ sparing.
Altogether, our results suggest that TRPV5 is the molecular target for the rapid PTH-induced stimulation of active Ca 2ϩ reabsorption in the distal part of the nephron. Activation of PTH1R initiates a signaling pathway, which involves cAMP and PKA that eventually results in the phosphorylation of threonine 709 and a subsequent increase in TRPV5 single-channel activity.
CONCISE METHODS
Molecular Biology and Cell Culture
Constructs containing TRPV5, TRPV6, or calbindin-D 28K in pCINeo/IRES-GFP were obtained as described previously. 47 Single PKA mutants were generated by alanine substitution of the threonine and serine residues of putative phosphorylation sites of TRPV5 (S142A, S680A, and T709A) using in vitro mutagenesis. TRPV5 Nand C-tail were cloned into the pGEX 6p-2 vector; subsequently, the previously described putative phosphorylation sites of TRPV5 were mutated into an alanine. The FRET sensor for Ca 2ϩ (yellow cameleon 2.1) was a gift of Dr. Tsien (University of California, San Diego, La Jolla, CA). FRET sensors for cAMP, CFP-Epac-YFP, 25 PIP 2 , eCFP-PH␦1, and eYFP␦1 were generated as described previously. 24 For the combined use of TRPV5 and both FRET sensors, IRES-GFP was removed from the original pCINEO/IRES-GFP vector. The PTH1R was a gift of Dr. Silver (Jerusalem, Israel). HEK293 cells were grown and transfected as described previously. 48 HEK293 cells stably expressing TRPV5 were generated as described previously 44 and maintained in medium containing 400 g/ml G418. 45 Ca 2؉ Uptake Radioactive Ca 2ϩ uptake was determined using TRPV5-and TRPV6expressing HEK293 cells seeded in poly-L-lysinecoated (Sigma, St. Louis, MO) 24-well plates. Cells were pretreated for 30 min with 25 M BAPTA-AM or 25 M EDTA-AM, subsequently incubated for 5 min in KHB buffer (110 mM NaCl, 5 mM KCl, 1.2 mM MgCl 2 , 0.1 mM CaCl 2 , 10 mM Na-acetate, 2 mM NaH 2 PO 4 , and 20 mM HEPES [pH 7.4]-NaOH), and finally incubated for 10 min with 45 CaCl 2 (1 Ci/ml) in KHB buffer with voltage-gated Ca 2ϩ channel inhibitors (10 M felodipine and 10 M verapamil). For blocking of TRPV5mediated 45 Ca 2ϩ uptake, cells were incubated with 10 M ruthenium red during the 5-and 10-min incubation steps. After multiple washing steps with ice-cold stop buffer (110 mM NaCl, 5 mM KCl, 1.2 mM MgCl 2 , 10 mM Na-acetate, 0.5 mM CaCl 2 , 1.5 mM LaCl 3 , and 20 mM HEPES [pH 7.4]-NaOH), the uptake of 45 Ca 2ϩ was measured.
Cell Surface Biotinylation and Immunoblotting
HEK293 cells stably expressing TRPV5 were seeded on poly-L-lysinecoated 10-cm dishes and treated similar as 45 Ca 2ϩ uptake assay. After 10 min of incubation with forskolin or ethanol (solvent) as a control, cells were placed on ice to inhibit intracellular trafficking processes. Subsequent biotinylation was performed on ice using 0.5 mg/ml sulfo-NHS-LC-LC-biotin (Pierce, Etten-leur, Netherlands) in PBS supplemented with 0.5 mM CaCl 2 and 1.0 mM MgCl 2 (PBS-CM) for 30 min. Unbound biotin was quenched with 0.1% (wt/vol) BSA in PBS-CM. Finally, cells were washed with PBS-CM and PBS and lysed in 150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl (pH 7.5), 1% (vol/vol) NP-40, 1 mM PMSF, 10 g/ml leupeptin, and 10 g/ml pepstatin A at 4°C. The lysate was centrifuged at 16,000 ϫ g, and biotinylated proteins were precipitated via neutravidin-coupled beads (Pierce) and analyzed by immunoblot using anti-TRPV5 antibody.
GST Pull-down and In Vitro Phosphorylation TRPV5 C-and N-tails fused to GST were purified as described previously. 49 The precipitated fusion proteins, immobilized on glutathione Sepharose 4B beads, were incubated for 30 min at 30°C in kinase reaction buffer (50 mM Tris-HCl [pH 7.5], 10 mM MgCl 2 , and 100 M ATP) containing the catalytic subunit of PKA (100 U/l reaction buffer; New England Biolabs, Leusden, The Netherlands) and 2 Ci of [␥ 32 P]ATP. For removing unbound [␥ 32 P]ATP, the beads were washed three times with 50 mM HEPES (pH 7.4)-KOH, 4 mM MnCl 2 , and 0.5 mM CaCl 2 . Proteins were eluted with SDS-PAGE loading buffer and separated on SDS-polyacrylamide gel, and in vitro phosphorylation was analyzed by autoradiography.
Dynamic FRET Assays
Cells grown on glass coverslips (diameter 24 mm) were transfected with FRET constructs (1 g per coverslip) , and experiments were performed as described previously. 24, 25 In brief, coverslips were placed on an inverted Nikon microscope (Düsseldorf, Germany) and excited at 425 nm using an ND3 filter. CFP and YFP emission was collected simultaneously through 470 Ϯ 20-and 530 Ϯ 25-nm bandpass filters. Data were acquired at two samples per second, and FRET was expressed as ratio of CFP to YFP signals. Calibration of CFP/YFP was accomplished by assessment of upper and lower saturation levels of the FRET sensors, resulting in ⌬FRET.
Electrophysiology
Patch-clamp experiments in the single-channel mode and perforated whole-cell configuration were performed as described previously 32 at room temperature using an EPC-9 patch-clamp amplifier computer controlled by the Pulse software (HEKA Elektronik, Lambrecht, Germany). For single-channel measurements in cell-attached mode, cells were perfused with the following solution: 140 mM KCl, 5 mM EDTA, 5 mM EGTA, 1 mM MgCl 2, 10 mM glucose, and 10 mM HEPES (pH 7.2)-KOH. For inside-out patches, excision was done in the same solution and 1 mM ATP was added. In both configurations, the pipette contained 140 mM NaCl, 10 mM EGTA, and 10 mM HEPES (pH 7.2)-NaOH. The sampling rate was 10 kHz; currents were filtered at 1 kHz. The analysis of single-channel data was performed using TAC software (Bruxton, Seattle, WA). Perforated whole-cell patchclamp analysis was performed as described previously. 50 For perforated patch recordings, 0.6 mg/ml of the pore-forming agent amphotericin B was added to the following pipette solution: 100 mM Cs-Aspartate, 20 mM CsCl, 1 mM MgCl 2 , and 10 mM HEPES (pH 7.2)-CsOH. Cells were kept and recorded in nominal divalent-free solution containing 150 mM NaCl, 6 mM CsCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, and 10 mM glucose (pH 7.4)-NaOH. The action of amphotericin B was visible as a continuous decrease in serial resistance. Recordings were started when the serial resistance attained values below 15 M⍀. BAPTA-AM (100 M) was used to chelate intracellular free Ca 2ϩ , after which forskolin (10 M) was added. Perforated whole-cell data were analyzed using Igor pro software (Wavemetrics, Lake, Oswego, OR).
Compounds
Full-length human PTH, human PTH (1 to 31), and bovine PTH (3 to 34) were purchased from Bachem AG (Bubendorf, Switzerland). Forskolin, amphotericin B, and the PKA inhibitor H-89 were purchased from Sigma.
Statistical Analysis
In all experiments, data are expressed as means Ϯ SEM. Overall statistical significance was determined by ANOVA. In case of significance, differences between the means of two groups were analyzed by paired and unpaired t test. P Ͻ 0.05 was considered significant.
